{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T18:37:30Z","timestamp":1726511850102},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Health, Labour and Welfare of Japan"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.lungcan.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T13:23:29Z","timestamp":1538918609000},"page":"253-257","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["New risk scoring system for predicting acute exacerbation of interstitial pneumonia after chemotherapy for lung cancer associated with interstitial pneumonia"],"prefix":"10.1016","volume":"125","author":[{"given":"Kazutoshi","family":"Isobe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyohei","family":"Kaburaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Go","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujiro","family":"Takai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Makino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naobumi","family":"Tochigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Iyoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakae","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lungcan.2018.10.008_bib0005","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1183\/09031936.01.99055301","article-title":"Lung cancer in patients with idiopathic pulmonary fibrosis","volume":"17","author":"Park","year":"2001","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.lungcan.2018.10.008_bib0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00595-006-3325-3","article-title":"Is interstitial pneumonia in patients with collagen diseases a contraindication to lung cancer surgery?","volume":"37","author":"Nakajima","year":"2007","journal-title":"Surg. Today"},{"issue":"4","key":"10.1016\/j.lungcan.2018.10.008_bib0015","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0022-5223(03)00791-8","article-title":"Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes","volume":"126","author":"Chiyo","year":"2003","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.lungcan.2018.10.008_bib0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/1096-9098(200101)76:1<53::AID-JSO1009>3.0.CO;2-T","article-title":"Clinicopathological characteristics of surgically resected lung cancer associated with idiopathic pulmonary fibrosis","volume":"76","author":"Kawasaki","year":"2001","journal-title":"J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2018.10.008_bib0025","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"Fibrosis, an official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.lungcan.2018.10.008_bib0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis. An International working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.lungcan.2018.10.008_bib0035","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1183\/09031936.00159709","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome","volume":"37","author":"Song","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.lungcan.2018.10.008_bib0040","first-page":"103","article-title":"Risk factors of acute exacerbation of idiopathic pulmonary fibrosis","volume":"27","author":"Kondoh","year":"2010","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"7","key":"10.1016\/j.lungcan.2018.10.008_bib0045","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/JTO.0b013e318216ee6b","article-title":"The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer","volume":"6","author":"Kenmotsu","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2018.10.008_bib0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1440-1843.2009.01666.x","article-title":"Clinical characteristics of acute respiratory deterioration in pulmonary fibrosis associated with lung cancer following anti-cancer therapy","volume":"15","author":"Isobe","year":"2010","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.lungcan.2018.10.008_bib0055","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/JTO.0b013e3182103d3c","article-title":"The feasibility study of carboplatin plus etoposide for advanced small cell lung cancer with idiopathic interstitial pneumonias","volume":"6","author":"Minegishi","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2018.10.008_bib0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.lungcan.2010.04.014","article-title":"The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias","volume":"71","author":"Minegishi","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2018.10.008_bib0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.lungcan.2016.03.017","article-title":"Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer","volume":"96","author":"Enomoto","year":"2016","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2018.10.008_bib0070","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00280-016-3040-8","article-title":"Safety and efficacy of S-1 in combination with carboplatin in non-small cell lung cancer patients with interstitial lung disease: a pilot study","volume":"77","author":"Sekine","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"9","key":"10.1016\/j.lungcan.2018.10.008_bib0075","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2169\/internalmedicine.48.1650","article-title":"Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy","volume":"48","author":"Minegishi","year":"2009","journal-title":"Intern. Med."},{"issue":"2","key":"10.1016\/j.lungcan.2018.10.008_bib0080","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1164\/rccm.201503-0562OC","article-title":"Efficacy of nintedanib in idiopathic pulmonary fibrosis across prespecified subgroups in INPULSIS","volume":"193","author":"Costabel","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.lungcan.2018.10.008_bib0085","first-page":"4259","article-title":"Efficacy and safety of combined carboplatin, paclitaxel, and bevacizumab for patients with advanced non-squamous non-small cell lung cancer with pre-existing interstitial lung disease: a retrospective multi-institutional study","volume":"35","author":"Enomoto","year":"2015","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.lungcan.2018.10.008_bib0090","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00280-015-2816-6","article-title":"Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung disease","volume":"76","author":"Enomoto","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"10","key":"10.1016\/j.lungcan.2018.10.008_bib0095","first-page":"4357","article-title":"Carboplatin plus weekly paclitaxel treatment in non-small cell lung cancer patients with interstitial lung disease","volume":"30","author":"Shukuya","year":"2010","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.lungcan.2018.10.008_bib0100","first-page":"1103","article-title":"Interstitial lung disease associated with docetaxel in patients with advanced non-small cell lung cancer","volume":"32","author":"Tamiya","year":"2012","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.lungcan.2018.10.008_bib0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1183\/09031936.00115511","article-title":"Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis","volume":"40","author":"Judge","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"21","key":"10.1016\/j.lungcan.2018.10.008_bib0110","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"N. Idiopathic Pulmonary Fibrosis Clinical Research","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2018.10.008_bib0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12931-016-0400-1","article-title":"Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis","volume":"17","author":"Kakugawa","year":"2016","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.lungcan.2018.10.008_bib0120","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11748-014-0487-6","article-title":"A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients","volume":"63","author":"Sato","year":"2015","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lungcan.2018.10.008_bib0125","series-title":"Idiopathic Interstitial Pneumonias: Diagnosis and Treatment","author":"The Japanese Respiratory Society","year":"2016"},{"issue":"4","key":"10.1016\/j.lungcan.2018.10.008_bib0130","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2214\/ajr.169.4.9308447","article-title":"Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring","volume":"169","author":"Kazerooni","year":"1997","journal-title":"AJR Am. J. Roentgenol."},{"issue":"4","key":"10.1016\/j.lungcan.2018.10.008_bib0135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0009-9260(82)80301-2","article-title":"Computed tomography in pulmonary emphysema","volume":"33","author":"Goddard","year":"1982","journal-title":"Clin. Radiol."},{"issue":"2","key":"10.1016\/j.lungcan.2018.10.008_bib0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1440-1843.2009.01676.x","article-title":"Clinical characteristics of combined pulmonary fibrosis and emphysema","volume":"15","author":"Kitaguchi","year":"2010","journal-title":"Respirology"},{"key":"10.1016\/j.lungcan.2018.10.008_bib0145","series-title":"The Annual Report by Study Group of Ministry of Health and Welfare for Diffuse Lung Disease Diffuse Lung Diseases Research Group from the Ministry of Health, Labour and Welfare of Japanese Government 2009","first-page":"105","author":"Gemma","year":"2010"},{"key":"10.1016\/j.lungcan.2018.10.008_bib0150","series-title":"The Annual Report by Study Group of Ministry of Health and Welfare for Diffuse Lung Disease, Diffuse Lung Diseases Research Group from the Ministry of Health, Labour and Welfare of Japanese Government 2012","first-page":"87","author":"Minegishi","year":"2013"},{"issue":"5","key":"10.1016\/j.lungcan.2018.10.008_bib0155","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ejrad.2015.01.021","article-title":"Interstitial lung abnormalities in treatment-naive advanced non-small-cell lung cancer patients are associated with shorter survival","volume":"84","author":"Nishino","year":"2015","journal-title":"Eur. J. Radiol."},{"issue":"6","key":"10.1016\/j.lungcan.2018.10.008_bib0160","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00280-014-2458-0","article-title":"Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung disease","volume":"73","author":"Choi","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.lungcan.2018.10.008_bib0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.lungcan.2018.06.032","article-title":"Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: meta-analysis of 153 cohorts with 15,713 patients: meta-analysis of incidence and risk factors of EGFR-TKI pneumonitis in NSCLC","volume":"123","author":"Suh","year":"2018","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2018.10.008_bib0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00280-015-2775-y","article-title":"Second-line docetaxel for patients with platinum-refractory advanced non-small cell lung cancer and interstitial pneumonia","volume":"76","author":"Watanabe","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"3","key":"10.1016\/j.lungcan.2018.10.008_bib0175","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJMc1505197","article-title":"Anti-PD-1-related pneumonitis during cancer immunotherapy","volume":"373","author":"Nishino","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.lungcan.2018.10.008_bib0180","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1158\/1078-0432.CCR-16-1320","article-title":"PD-1 inhibitor-related pneumonitis in advanced cancer patients: radiographic patterns and clinical course","volume":"22","author":"Nishino","year":"2016","journal-title":"Clin. Cancer Res."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218305920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218305920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T01:30:33Z","timestamp":1540517433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500218305920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":36,"alternative-id":["S0169500218305920"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.10.008","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New risk scoring system for predicting acute exacerbation of interstitial pneumonia after chemotherapy for lung cancer associated with interstitial pneumonia","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}